| First Author | Unoki M | Year | 2008 |
| Journal | FEBS Lett | Volume | 582 |
| Issue | 28 | Pages | 3868-74 |
| PubMed ID | 18951897 | Mgi Jnum | J:144876 |
| Mgi Id | MGI:3832127 | Doi | 10.1016/j.febslet.2008.10.024 |
| Citation | Unoki M, et al. (2008) A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis. FEBS Lett 582(28):3868-74 |
| abstractText | We identified a novel inhibitor of growth family member 2 (ING2) isoform, ING2b, which shares exon 2 with ING2a, but lacks the N-terminal p53 binding region. Contrary to ING2a, ING2b's promoter has no p53 binding sites. Consistently, activation of p53 led to suppression of ING2a, leaving ING2b unaffected. Through isoform-specific targeting, we showed that ING2a knockdown suppressed cell growth only in the presence of p53, ING2b knockdown had no effect on cell growth, and knockdown of both induced cell cycle arrest and apoptosis independently of p53. ING2a and ING2b have compensatory roles that protect cells from cell cycle arrest and apoptosis and may be involved in development of chemotherapeutic resistance. |
